Association between matrix metalloproteinase-2 and matrix metalloproteinase-9 polymorphisms and endometriosis: A systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biomedical Reports

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/BR.2015.447PMID 26171166PMCID PMC4486806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endometriosis

  2015cited by this paper
• Genetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasets

  2014cited by this paper
• Matrix metalloproteinases’s association of polymorphisms of MMP3 and MMP9 with development of genital endometriosis

  2014cited by this paper
• [Association of matrix metalloproteinases' polymorphisms of MMP3 and MMP9 with development of genital endometriosis].

  2014cited by this paper
• Association between CD14 Gene Polymorphisms and Cancer Risk: A Meta-Analysis

  2014cited by this paper
• Matrix metalloproteinases’s association of polymorphisms of MMP3 and MMP9 with development of genital endometriosis

  2014cited by this paper
• European Accreditation of Endometriosis Centers of Expertise

  2013cited by this paper
• [Matrix metalloproteinases and their tissue inhibitors].

  2012cited by this paper
• Insights into Assessing the Genetics of Endometriosis

  2012cited by this paper
• Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis.

  2010cited by this paper
• Endometriosis: new concepts in the pathogenesis.

  2010cited by this paper
• Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced-stage endometriosis.

  2009cited by this paper
• Association of polymorphisms of the MMP-2 and TIMP-2 genes with the risk of endometriosis in North Chinese women.

  2008cited by this paper
• The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study.

  2005cited by this paper
• Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9.

  2004cited by this paper
• Endometriosis and the neoplastic process.

  2004cited by this paper
• Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis.

  2004cited by this paper
• Matrix Metalloproteinases and Endometriosis

  2003cited by this paper
• Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium.

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Angiogenesis extent and expression of matrix metalloproteinase‐2 and ‐9 agree with progression of ovarian endometriomas

  2002cited by this paper
• Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness.

  2001cited by this paper
• Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

  1999cited by this paper
• Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2–13.1

  1999cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Quantitative Synthesis in Systematic Reviews

  1997cited by this paper
• The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis.

  1994cited by this paper
• Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis

  1993cited by this paper
• Genetic control of cancer metastasis.

  1990cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Endometriosis: Pathogenetic Implications of the Anatomic Distribution

  1986cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Impaired Decidualization and Angiogenesis in Eutopic Endometrium of Endometriosis: Insights from In Vitro Models.

  2025cites this paper
• Unveiling the fibrotic puzzle of endometriosis: An overlooked concern calling for prompt action

  2024cites this paper
• MCP-1 exerts the inflammatory response via ILK activation during endometriosis pathogenesis.

  2024cites this paper
• A molecular network-based pharmacological study on the protective effect of Panax notoginseng rhizomes against renal ischemia–reperfusion injury

  2023cites this paper
• Features of Matrix Metalloproteinases MMP2, MMP3, and MMP9 of Regulatory-Region Polymorphism in Patients with Uterine Fibroids

  2023cites this paper
• Features of matrix metalloproteinases MMP2, MMP3, MMP9 genes regulatory region polymorphism in patients with uterine fbroids

  2023cites this paper
• Effect of Phaleria macrocarpa Extract on NF-KB, MMP-2, and MMP-9 Expression in Endometriosis Mice Model

  2022cites this paper
• Matrix Metalloproteinases 2 and 9 and Their Tissue Inhibitors in the Diagnostics of Medullary Thyroid Carcinoma

  2022cites this paper
• Chloride Channel and Inflammation-Mediated Pathogenesis of Osteoarthritis

  2022cites this paper
• Ion Channels in The Pathogenesis of Endometriosis: A Cutting-Edge Point of View

  2020cites this paper
• Age at Menarche and Oxidative Stress Markers in Women with Endometriosis

  2020cites this paper
• Immunoexpression of matrix metalloproteinases MMP-1, MMP-2, MMP-9 and MMP-14 in extragenital endometriosis and eutopic endometrium

  2020cites this paper
• Fibrinogen alpha chain is up-regulated and affects the pathogenesis of endometriosis.

  2019cites this paper
• Lipoxin A4 Suppresses Estrogen-Induced Epithelial–Mesenchymal Transition via ALXR-Dependent Manner in Endometriosis

  2018cites this paper
• [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].

  2018cites this paper
• [The expression of moesin, p21-activated kinase 4 (PAK 4), matrix metalloproteinases (MMP 2, MMP 9), and CD34 in the eutopic and ectopic endometrium in adenomyosis].

  2018cites this paper
• The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis

  2018cites this paper
• Matrix metalloproteinase and tissue inhibitors of metalloproteinases gene polymorphisms in disorders that influence fertility and pregnancy complications: A systematic review and meta-analysis.

  2018cites this paper
• Traitements médicamenteux de l’endométriose (adénomyose exclue)

  2017cites this paper
• Magnesium isoglycyrrhizinate protects against renal‑ischemia‑reperfusion injury in a rat model via anti‑inflammation, anti‑oxidation and anti‑apoptosis.

  2017cites this paper
• Pentoxifylline exerts anti-inflammatory effects on cerebral ischemia reperfusion‑induced injury in a rat model via the p38 mitogen-activated protein kinase signaling pathway.

  2017cites this paper
• [Medical treatment of endometriosis: Hormonal treatment of pain, impact on evolution and future perspectives].

  2017cites this paper
• Pharmacological treatment of endometriosis: review of current and new options for treatment

  2016cites this paper